System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Jason G Andrade is an expert in Cardiology at Montreal Heart Institute (Canada). As of October 2026, ScienceLeadR ranks Jason G Andrade in the top 1% of experts worldwide for Atrial Fibrillation and Arrhythmias, Cardiac. Jason G Andrade has authored 404 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 4 of them ongoing. SLR score: 1,799 (community average: 125). How the SLR is computed.

LeadR Profile

Jason G Andrade Montreal Heart Institute Canada
1 799 ScienceLeadR Reputation 1799

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Pharmacy - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026
Source: PubMed

University of British Columbia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 404

Citations

Citations: 11 816 1st author: 108 Last author: 62 Unique author: 9

Main journals

Heart Rhythm 52
Can J Cardiol 48
JACC Clin Electrophysiol 26
Europace 24
Circulation 18

Best Journals

Circulation 12
N Engl J Med 11
Eur Heart J 6

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The future of PFA in cardiac ablation procedures.
PMID 42905910 — safety, therapeutics, catheter ablation, catheters		Europace20260
Pulsed Field Ablation for Persistent Atrial Fibrillation. Reply.
PMID 42906105 — atrial fibrillation, pulsed field ablation		N Engl J Med Top journal20260
Incorporating a Shortened Long-Term Effectiveness END Point Into Catheter Ablation Trials: Statistical Properties and Implications.
PMID 42755699 — atrial flutter, arrhythmias, cardiac, atrial fibrillation, catheter ablation, catheters, survival rate		Circ Arrhythm Electrophysiol20260
Practical Guide on the Use of the PulseSelect Pulsed Field Ablation System for Atrial Fibrillation Ablation Procedures.
PMID 42644575 — atrial fibrillation, catheters, pulsed field ablation		Europace20260
Erratum: Author Correction to "Variation in Availability of Continuous Ambulatory Electrocardiographic Monitors Across Canadian Provinces [CJC Open. Volume 7, Issue 9, Pages 1157-1161. DOI:doi.org/10.1016/j.cjco.2025.06.005]".
PMID 42609735		CJC Open20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 13
Phase 3 5
Phase 4 3

By status:

Completed 12
Active not recruiting 3
Terminated 3
Recruiting 2
Not yet recruiting 1

By type:

Interventional 18
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 1
multicentricup10 13

Main Topics

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Optimal PharmacoTherapy and Invasive Management of Atrial Fibrillation in Patients With Heart Failure
NCT07238452 — pulmonary veins, quality of life, mortality, heart failure, heart, drug therapy, atrial fibrillation, heart failure, systolic, morbidity, therapeutics, catheter ablation, veins, cardiomyopathies, catheters, pulsed field ablation		Phase 3Not yet recruiting2026
PulseSelect PFA Global Registry
NCT06393920 — registries, atrial fibrillation		N/ARecruiting2024
Pulsed Field Ablation (PFA) vs Anti Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
NCT06096337 — pulmonary veins, heart diseases, pharmaceutical preparations, propafenone, heart, cardiovascular diseases, sotalol, atrial fibrillation, anti-arrhythmia agents, drug delivery systems, therapeutics, flecainide, veins, dronedarone, pulsed field ablation		N/AActive not recruiting2023
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
NCT05293080 — ischemic stroke, stroke, pharmaceutical preparations, propafenone, arrhythmias, cardiac, atrial fibrillation, amiodarone, anti-arrhythmia agents, therapeutics, flecainide, dronedarone		Phase 3Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS